Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target
Looking for successors to the blockbuster GLP-1 obesity drugs, companies like Novo Nordisk and Eli Lilly are testing amylin hormone receptor treatments. The hope is for less nausea and muscle loss.